Alan Higgins
Corporate Officer/Principal bei The University of North Carolina at Charlotte
Profil
Alan Higgins is Vice President of Preclinical Development for Viamet Pharmaceuticals, Inc. He is an Adjunct Associate Professor in the School of Pharmacy at the University of North Carolina.
Prior to joining Viamet, he worked for Cogenics, Inc. and Nobex Corp.
Dr. Higgins was Director of Cardiovascular and Neurobiology Research for Allelix Biopharmaceuticals, Inc. and Director of Metabolic Diseases for Oncogene Science, Inc. and Hoffman-LaRoche F & Co. AG.
He was a Member of the British Society for Cardiovascular Research and the Technical Advisory Board for the Metabolomics Society.
Dr. Higgins began his career at Pfizer Central Research.
He has over 30 years of experience in pharmaceutical and biotechnology companies.
Dr. Higgins received a BSc degree in Biochemistry from the University of Edinburgh and a PhD in Pharmacology from the Council for National Academic Awards.
Aktive Positionen von Alan Higgins
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Alan Higgins
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Corporate Officer/Principal | - |
| Allelix Biopharmaceuticals, Inc. | Corporate Officer/Principal | - |
Nobex Corp.
 Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Corporate Officer/Principal | - |
| Cogenics, Inc. | Corporate Officer/Principal | - |
Ausbildung von Alan Higgins
| The University of Edinburgh | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Health Technology |
| Cogenics, Inc. | |
Nobex Corp.
Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Health Technology |
| Allelix Biopharmaceuticals, Inc. | Health Technology |
Hoffman-LaRoche F & Co. AG
Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
